(Q46190981)

20 December 2017

title

Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas (English)

1 reference

20 December 2017

author

Thierry Brue

7

1 reference

20 December 2017

Paolo Cappabianca

8

1 reference

20 December 2017

Annamaria Colao

9

object named as

Annamaria Colao

1 reference

20 December 2017

Janet A Schlechte

3

0 references

Josef Marek

object named as

Josef Marek

16

0 references

Edward R. Laws

15

object named as

Edward Laws

1 reference

20 December 2017

author name string

Felipe F Casanueva

1

1 reference

20 December 2017

Mark E Molitch

2

1 reference

20 December 2017

Roger Abs

4

1 reference

20 December 2017

Vivien Bonert

5

1 reference

20 December 2017

Marcello D Bronstein

6

1 reference

20 December 2017

Rudolf Fahlbusch

10

1 reference

20 December 2017

Hugo Fideleff

11

1 reference

20 December 2017

Moshe Hadani

12

1 reference

20 December 2017

Paul Kelly

13

1 reference

20 December 2017

David Kleinberg

14

1 reference

20 December 2017

Maurice Scanlon

17

1 reference

20 December 2017

Luis G Sobrinho

18

1 reference

20 December 2017

John A H Wass

19

1 reference

20 December 2017

Andrea Giustina

20

1 reference

20 December 2017

publication date

1 August 2006

1 reference

20 December 2017

published in

Clinical Endocrinology

1 reference

20 December 2017

volume

65

1 reference

20 December 2017

issue

2

1 reference

20 December 2017

page(s)

265-273

1 reference

20 December 2017

Clinical practice. Prolactinoma

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Hyperprolactinemia: pathophysiology and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Pituitary disease in MEN type 1 (MEN1): data from the France-Belgium MEN1 multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Clinical review 136: Primary lymphoma of the pituitary: an emerging clinical entity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Medical management of prolactin-secreting pituitary adenomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Criteria for cure of acromegaly: a consensus statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

The impact on clinical practice of routine screening for macroprolactin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Screening for macroprolactinaemia and pituitary imaging studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

An audit of the diagnostic usefulness of PRL and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Current approaches to imaging of the sellar region and pituitary

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Dopamine agonists and pituitary tumor shrinkage

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

A comparison of cabergoline and bromocriptine in the treatment of hyperprolactinemic amenorrhea. Cabergoline Comparative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Long-term follow-up of patients with hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

The effect of the menopause on prolactin levels in patients with hyperprolactinaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Growth hormone secretion elicited by GHRH, GHRP-6 or GHRH plus GHRP-6 in patients with microprolactinoma and macroprolactinoma before and after bromocriptine therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Dopamine resistance of prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Current management of prolactinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Ten year follow up of microprolactinoma treated by transsphenoidal surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Long-term treatment with cabergoline, a new long-lasting ergoline derivate, in idiopathic or tumorous hyperprolactinaemia and outcome of drug-induced pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Successful treatment of a large macroprolactinoma with cabergoline during pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Pregnancy outcome after cabergoline treatment in early weeks of gestation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Pregnancy outcome after treatment with the ergot derivative, cabergoline.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Reproductive toxicity of cabergoline in mice, rats, and rabbits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

Withdrawal of long-term cabergoline therapy for tumoral and nontumoral hyperprolactinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2265.2006.02562.X

10.1111/J.1365-2265.2006.02562.X

21 January 2018

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017